Cargando…

Predicting the probability of pT3 or higher pathological stage at radical prostatectomy: COVID19-specific considerations

BACKGROUND: We tested whether a model identifying prostate cancer (PCa) patients at risk of pT3-4/pN1 can be developed for use during COVID19 pandemic, in order to guarantee appropriate treatment to patients harboring advanced disease patients without compromising sustainability of care delivery. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nocera, Luigi, Stolzenbach, Lara F., Collà Ruvolo, Claudia, Wenzel, Mike, Wurnschimmel, Christoph, Tian, Zhe, Gandaglia, Giorgio, Fossati, Nicola, Mirone, Vincenzo, Chun, Felix K. H., Shariat, Shahrokh F., Graefen, Markus, Saad, Fred, Montorsi, Francesco, Briganti, Alberto, Karakiewicz, Pierre I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763886/ https://www.ncbi.nlm.nih.gov/pubmed/36561531 http://dx.doi.org/10.3389/fonc.2022.990851

Ejemplares similares

The effect of race/ethnicity on cancer-specific mortality after salvage radical prostatectomy
por: Wenzel, Mike, et al.
Publicado: (2022)

Race/Ethnicity may be an Important Predictor of Life Expectancy in Localized Prostate Cancer Patients: Novel Analyses Using Social Security Administration Life Tables
por: Würnschimmel, Christoph, et al.
Publicado: (2022)

Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
por: Wenzel, Mike, et al.
Publicado: (2021)

Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
por: Wenzel, Mike, et al.
Publicado: (2023)

Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicities
por: Würnschimmel, Christoph, et al.
Publicado: (2021)

Comparison between 1973 and 2004/2016 World Health Organization grading in upper tract urothelial carcinoma treated with radical nephroureterectomy
por: Collà Ruvolo , Claudia, et al.
Publicado: (2021)

Differences between rural and urban prostate cancer patients
por: Stolzenbach, Lara Franziska, et al.
Publicado: (2020)

Incidence rates and contemporary trends in primary urethral cancer
por: Wenzel, Mike, et al.
Publicado: (2021)

The Effect of 10 Most Common Nonurological Primary Cancers on Survival in Men With Secondary Prostate Cancer
por: Wenzel, Mike, et al.
Publicado: (2021)

Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinoma
por: Wenzel, Mike, et al.
Publicado: (2021)

Penile rehabilitation after radical prostatectomy: does it work?
por: Gandaglia, Giorgio, et al.
Publicado: (2015)

Survival after radical prostatectomy versus radiation therapy in clinical node‐positive prostate cancer
por: Chierigo, Francesco, et al.
Publicado: (2022)

Radiation therapy after radical prostatectomy is associated with higher other-cause mortality
por: Würnschimmel, Christoph, et al.
Publicado: (2022)

Anastomotic leaks and catheter time after salvage robot-assisted radical prostatectomy
por: Bandini, Marco, et al.
Publicado: (2018)

Comparison Between Urothelial and Non-Urothelial Urethral Cancer
por: Wenzel, Mike, et al.
Publicado: (2021)

Bladder cancer stage and mortality: urban vs. rural residency
por: Deuker, Marina, et al.
Publicado: (2020)

Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy: Extended, of Course
por: Gandaglia, Giorgio, et al.
Publicado: (2022)

Epidemiology of Unconventional Histological Subtypes of Urethral Cancer
por: Wenzel, Mike, et al.
Publicado: (2023)

Racial differences in the distribution of bladder cancer metastases: a population-based analysis
por: Rosiello, Giuseppe, et al.
Publicado: (2020)

An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer
por: Bandini, Marco, et al.
Publicado: (2017)

Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients
por: Hoeh, Benedikt, et al.
Publicado: (2021)

An external validation of the nocera nomogram: Predicting non-organ confined stage of ≥pT3 in cT1 clear cell renal cell carcinoma
por: Wenzel, Mike, et al.
Publicado: (2022)

Orphaned Side-effects After Robot-assisted Radical Prostatectomy: Is the Retzius-sparing Approach Superior to the Standard Approach or Are the Data Just Not Mature Enough?
por: Würnschimmel, Christoph, et al.
Publicado: (2021)

Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients
por: Hoeh, Benedikt, et al.
Publicado: (2021)

Differences in rates of pelvic lymph node dissection in National Comprehensive Cancer Network favorable, unfavorable intermediate- and high-risk prostate cancer across United States SEER registries
por: Flammia, Rocco Simone, et al.
Publicado: (2022)

Contemporary seminal vesicle invasion rates in NCCN high‐risk prostate cancer patients
por: Flammia, Rocco S., et al.
Publicado: (2022)

North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients
por: Preisser, Felix, et al.
Publicado: (2018)

Primary lymphomas of the genitourinary tract: A population-based study
por: Palumbo, Carlotta, et al.
Publicado: (2020)

Grade and stage misclassification in intermediate unfavorable‐risk prostate cancer radiotherapy candidates
por: Sorce, Gabriele, et al.
Publicado: (2022)

Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients
por: Flammia, Rocco S., et al.
Publicado: (2022)

The association of the type and number of D’Amico high-risk criteria with rates of pathologically non-organ-confined prostate cancer
por: Chierigo, Francesco, et al.
Publicado: (2023)

The Effect of Sex on Disease Stage and Survival after Radical Cystectomy in Non-Urothelial Variant-Histology Bladder Cancer
por: Flammia, Rocco Simone, et al.
Publicado: (2023)

Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype
por: Barletta, Francesco, et al.
Publicado: (2022)

Prostate Cancer: Is There Still a Role for Systematic Biopsies? Yes
por: Gandaglia, Giorgio, et al.
Publicado: (2022)

Racial/ethnic disparities in the distribution and effect of type and number of high-risk criteria on mortality in prostate cancer patients treated with radiotherapy
por: Chierigo, Francesco, et al.
Publicado: (2022)

Evidence-Based Comparison of Robotic and Open Radical Prostatectomy
por: Lowrance, William T., et al.
Publicado: (2010)

Correlation of MRI-Lesion Targeted Biopsy vs. Systematic Biopsy Gleason Score with Final Pathological Gleason Score after Radical Prostatectomy
por: Wenzel, Mike, et al.
Publicado: (2021)

Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review
por: Laukhtina, Ekaterina, et al.
Publicado: (2021)

Sex-related differences in non-urothelial variant histology, non-muscle invasive bladder cancer
por: Flammia, Rocco Simone, et al.
Publicado: (2022)

Prevention and management of post prostatectomy erectile dysfunction
por: Salonia, Andrea, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fgkg28el10fo6fb70gd4m8hr7v